Intro; Preface; Contents; Chapter 1: Liver Involvement in Rheumatic Diseases; 1.1 Introduction; 1.2 Prevalence of Liver Dysfunction in Patients with Rheumatic Diseases; 1.3 Laboratory Findings; 1.4 Histologic Findings; 1.5 Image Findings; 1.6 Liver Dysfunction Associated with Rheumatic Diseases Alone; 1.6.1 Systemic Lupus Erythematosus; 1.6.2 Rheumatoid Arthritis; 1.7 Autoimmune Liver Disease; 1.7.1 Autoimmune Hepatitis; 1.7.2 Primary Biliary Cholangitis; 1.8 Viral Infection; 1.8.1 Hepatitis C Virus; 1.8.2 Other Viruses; 1.9 Drug-Induced Liver Injury; 1.10 Fatty Liver

1.11 Acute Liver Failure1.12 Conclusion; References; Chapter 2: Primary Biliary Cholangitis Is Associated with CREST Syndrome; 2.1 Introduction; 2.2 Epidemiology; 2.3 Etiology; 2.4 Clinical Features; 2.5 Nail-Fold Capillaroscopy; 2.6 Prognosis; 2.7 Conclusion; References; Chapter 3: De Novo Hepatitis B Virus Infection; 3.1 Introduction; 3.2 Definition of HBV Reactivation; 3.3 HBV Reactivation Risk and Frequency; 3.4 Rheumatic and Connective Tissue Disorders and HBV Reactivation; 3.5 HBV Reactivation Guidelines; 3.6 Treatment for HBV Reactivation

3.7 Reference Guide for Ending Nucleic Acid Analogue Administration3.8 Management of Hepatic Dysfunction Onset During or After Immunosuppressive Therapy for Rheumatic Disorders; 3.9 Conclusion; References; Chapter 4: Dermatomyositis and Gastrointestinal Cancer; 4.1 Introduction; 4.2 Incidence of Malignancy in DM; 4.3 Pathogenesis; 4.4 Type of Gastroenterological Malignancy; 4.5 Timing of Cancer; 4.6 Risk Factor; 4.6.1 Demographics; 4.6.2 Skin Manifestation; 4.6.3 Muscle Histology; 4.6.4 Laboratory Marker; 4.6.5 Others; 4.7 Screening; 4.8 Prognosis and Treatment; 4.9 Case Presentation

4.9.1 DM and Colon Cancer4.9.2 DM and Oesophageal Cancer; References; Chapter 5: Portal Hypertension in Rheumatic Diseases; 5.1 Introduction; 5.2 Portal Hypertension; 5.2.1 Rheumatic Diseases and Portal Hypertension; 5.2.2 Conditions Characterized by Portal Hypertension in Rheumatic Diseases; 5.2.2.1 Idiopathic Portal Hypertension (IPH); 5.2.2.2 Pulmonary Hypertension; 5.2.2.3 Primary Biliary Cholangitis (PBC)-CREST Syndrome; 5.2.3 Complications in Portal Hypertension and Their Treatment; 5.2.3.1 Esophagogastric Varices; 5.2.3.2 Splenomegaly and Hypersplenism; 5.2.3.3 Ascites Fluid

5.3 Case Presentation5.3.1 Case 1: A Patient with SLE Complicated by IPH and Aplasia Pure Red Cell; 5.3.2 Case 2: A Patient with SLE Complicated by Pulmonary Hypertension; 5.3.3 Case 3: A Patient with Sjogren's Syndrome Complicated by Pulmonary Hypertension; 5.3.4 Case 4: A Patient with MCTD Complicated by IPH and Pulmonary Hypertension; 5.4 Conclusion; References; Chapter 6: Gastrointestinal Manifestations of Systemic Lupus Erythematosus; 6.1 Introduction; 6.2 Case Presentations; 6.2.1 Case 1: Lupus Enteritis with Small Bowel Wall Thickening